Press Release
March 19, 2019
Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial
More
March 12, 2019
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018
More
March 7, 2019
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019
More
January 3, 2019
Amphastar Pharmaceuticals, Inc. Announces Launch of Primatene® MIST to Nationwide Retail Pharmacies
More
November 20, 2018
Amphastar Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference 2018
More
November 9, 2018
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018
More
November 8, 2018
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018
More
November 2, 2018
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018
More
August 29, 2018